Kyle Lefkoff, Director at MIRAGEN THERAPEUTICS, INC. (MGEN), sold 10,004 shares at $14.36 ($142K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Open-market sale of $142k MGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.36 | 4,102 | $59K | 41.4% |
| 2 | $14.36 | 4,102 | $59K | 41.4% |
| 3 | $13.65 | 1,800 | $25K | 17.3% |
| Total | $14.23 avg | 10,004 | $142K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |